COMPANY
OrSense
Timeline
- Trial start —: A Trial to Evaluate the Precision and Accuracy of the NBM-200 Series When Used in a Continuous Prospective Mode source ↗
- Trial start —: Evaluate the Accuracy of the NBM200 for Noninvasive Hemoglobin Measurements on Obstetric/Gynecological Patients source ↗
- Trial start —: A Clinical Evaluation of the OrSense Non-invasive Blood Hb/Hct Measurement Instrument, the Hemo-Monitor NBM200/MP source ↗
Clinical trials (lead sponsor) 3
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT01917487 | A Trial to Evaluate the Precision and Accuracy of the NBM-200 Series When Used in a Continuous Prospective Mode | Not listed | Unknown status (ClinicalTrials.gov) | 2011-11 | 2013-10 (estimated) |
| NCT01917851 | Evaluate the Accuracy of the NBM200 for Noninvasive Hemoglobin Measurements on Obstetric/Gynecological Patients | Not listed | Unknown status (ClinicalTrials.gov) | 2011-04 | 2013-08 (estimated) |
| NCT01915953 | A Clinical Evaluation of the OrSense Non-invasive Blood Hb/Hct Measurement Instrument, the Hemo-Monitor NBM200/MP | Not listed | Unknown status (ClinicalTrials.gov) | 2011-02 | 2013-10 (estimated) |